Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Traws Pharma, Inc. - Common Stock (NQ:TRAW)

1.460 -0.020 (-1.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,664
Open 1.460
Bid (Size) 1.460 (4)
Ask (Size) 1.500 (88)
Prev. Close 1.480
Today's Range 1.440 - 1.485
52wk Range 0.9801 - 19.44
Shares Outstanding 5,564,315
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
From Traws Pharma, Inc.
Via GlobeNewswire
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-83.2%
-83.2%
1 Month
+2.8%
+2.8%
3 Month
-31.8%
-31.8%
6 Month
-83.6%
-83.6%
1 Year
-86.5%
-86.5%

More News

Read More
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!
Via AB Newswire
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Dow Gains Over 100 Points; US Job Openings Increase In April
Via Benzinga
Topics Stocks
Tuesday's session: gap up and gap down stocks
Via Chartmill
US Stocks Mixed; Dollar General Posts Upbeat Earnings
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Reports Full Year 2024 Results and Business Highlights
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Announces Management Updates
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
From Traws Pharma, Inc.
Via GlobeNewswire
Monday's pre-market session: top gainers and losers
Via Chartmill
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
From Traws Pharma, Inc.
Via GlobeNewswire
Thursday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Traws Pharma, Inc. - Common Stock publicly traded?
Yes, Traws Pharma, Inc. - Common Stock is publicly traded.
What exchange does Traws Pharma, Inc. - Common Stock trade on?
Traws Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Traws Pharma, Inc. - Common Stock?
The ticker symbol for Traws Pharma, Inc. - Common Stock is TRAW on the Nasdaq Stock Market
What is the current price of Traws Pharma, Inc. - Common Stock?
The current price of Traws Pharma, Inc. - Common Stock is 1.460
When was Traws Pharma, Inc. - Common Stock last traded?
The last trade of Traws Pharma, Inc. - Common Stock was at 07/01/25 04:00 PM ET
What is the market capitalization of Traws Pharma, Inc. - Common Stock?
The market capitalization of Traws Pharma, Inc. - Common Stock is 8.12M
How many shares of Traws Pharma, Inc. - Common Stock are outstanding?
Traws Pharma, Inc. - Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.